Neuronal ceroid lipofuscinosis in a Schapendoes dog is caused by a missense variant in CLN6

• Published in: Animal genetics 2024-08, Vol.55 (4), p.612-620
• Main Authors: Bellamy, Kim K. L., Skedsmo, Fredrik S., Hultman, Josefin, Jansen, Johan Høgset, Lingaas, Frode
• Format: Article
• Language: English
• Subjects: Central nervous system; CLN6; dog; Dogs; Epilepsy; Gene sequencing; lysosomal storage disease; Lysosomal storage diseases; missense variant; Neurodegenerative diseases; Neuronal ceroid lipofuscinosis; Schapendoes; Seizures; Sensorimotor integration; Visual perception; Whole genome sequencing
• ISSN: 0268-9146; 1365-2052; 1365-2052
• DOI: 10.1111/age.13457

Neuronal ceroid lipofuscinosis (NCL) is a group of neurodegenerative disorders that occur in humans, dogs, and several other species. NCL is characterised clinically by progressive deterioration of cognitive and motor function, epileptic seizures, and visual impairment. Most forms present early in life and eventually lead to premature death. Typical pathological changes include neuronal accumulation of autofluorescent, periodic acid‐Schiff‐ and Sudan black B‐positive lipopigments, as well as marked loss of neurons in the central nervous system. Here, we describe a 19‐month‐old Schapendoes dog, where clinical signs were indicative of lysosomal storage disease, which was corroborated by pathological findings consistent with NCL. Whole genome sequencing of the affected dog and both parents, followed by variant calling and visual inspection of known NCL genes, identified a missense variant in CLN6 (c.386T>C). The variant is located in a highly conserved region of the gene and predicted to be harmful, which supports a causal relationship. The identification of this novel CLN6 variant enables pre‐breeding DNA‐testing to prevent future cases of NCL6 in the Schapendoes breed, and presents a potential natural model for NCL6 in humans.